lobbying_activities: 1738267

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1738267	9373b789-58e9-4e51-af0d-7973386e7b3d	Q3	WALTER CONSULTING	301697	AMERISOURCEBERGEN CORPORATION	2015	third_quarter	PHA	H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2015-10-19T12:18:48.027000-04:00